Log in

Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

To determine the antimicrobial resistance profiles among clinical isolates of Enterobacteriaceae in Taiwanese intensive care units (ICUs), a national surveillance of antibiotic resistance among important Enterobacteriaceae was conducted from September 2005 through November 2005 at the ICUs of ten major teaching hospitals in Taiwan. A total of 574 Enterobacteriaceae isolates recovered from various clinical samples of our ICU patients were submitted for in vitro test. Minimum inhibitory concentrations (MICs) of these isolates to 18 antimicrobial agents were determined by the broth microdilution method. The prevalences of Enterobacteriaceae isolates with phenotypic extended-spectrum β-lactamase (ESBL) production were 26% in Klebsiella pneumoniae, 16% in Serratia marcescens, 14% in Escherichia coli, and 13% in Proteus mirabilis, in which a significantly rising prevalence of ESBL production among K. pneumoniae was noted (p = 0.002) when compared with a previous Taiwanese survey in 2000. Heterogeneous resistance to various fluoroquinolones was found among our Enterobacteriaceae isolates, except for Entetrobacter cloacae. Emergence of ertapenem-resistant isolates of E. coli, K. pneumoniae, E. cloacae, and S. marcescens was noted. Gradually increasing rates of drug-resistant Enterobacteriaceae were noted in Taiwanese ICUs. Periodic surveillance of the evolutionary trend of antimicrobial resistance among ICU isolates is crucial for starting appropriately empirical antimicrobial therapy in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hsueh PR, Liu YC, Yang D, Yan JJ, Wu TL, Huang WK et al (2001) Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 7:373–382. doi:10.1089/10766290152773383

    Article  PubMed  CAS  Google Scholar 

  2. Ho PL, Chan WM, Tsang KW, Wong SS, Young K (2002) Bacteraemia caused by Escherichia coli producing extended-spectrum β-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 34:567–573. doi:10.1080/00365540210147516

    Article  PubMed  Google Scholar 

  3. Clinical and Laboratory Standards Institute (2005) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. Approved standard M7-A6. CLSI, Wayne, PA, USA

  4. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing—fifteenth informational supplement. M100-S15. CLSI, Wayne, PA, USA

  5. Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V et al (2005) In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 55:965–973. doi:10.1093/jac/dki117

    Article  PubMed  CAS  Google Scholar 

  6. Streit JM, Jones RN, Sader HS, Fritsche TR (2004) Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Programme (North America, 2001). Int J Antimicrob Agents 24:111–118. doi:10.1016/j.ijantimicag.2003.12.019

    Article  PubMed  CAS  Google Scholar 

  7. Gales AC, Sader HHS, Jones RN (2002) Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis 44:301–311. doi:10.1016/S0732–8893(02)00499–6

    Article  PubMed  Google Scholar 

  8. Jacoby GA, Mills DM, Chow N (2004) Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:3203–3206. doi:10.1128/AAC.48.8.3203–3206.2004

    Article  PubMed  CAS  Google Scholar 

  9. Mammeri H, Nordmann P, Berkani A, Eb F (2008) Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett 282:238–240. doi:10.1111/j.1574–6968.2008.01126.x

    Article  PubMed  CAS  Google Scholar 

  10. Szabó D, Silveira F, Hujer AM, Bonomo RA, Hujer KM, Marsh JW et al (2006) Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob Agents Chemother 50:2833–2835. doi:10.1128/AAC.01591–05

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P.-R. Hsueh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jean, SS., Hsueh, PR., Lee, WS. et al. Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan. Eur J Clin Microbiol Infect Dis 28, 215–220 (2009). https://doi.org/10.1007/s10096-008-0610-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0610-7

Keywords

Navigation